Antigen Binding Articles & Analysis
10 news found
The platform covers both linear and conformational epitope analysis and includes the following core services: l Binding Activity Confirmation: ELISA or Western blot assays to verify the interaction between the submitted antibody and antigen. l Glycosylation Analysis (Optional): Comparing antibody binding to glycosylated versus deglycosylated ...
This capability is ideal for modifying enzyme active sites, mapping interaction domains, or optimizing antibody-antigen binding interfaces. For projects that demand high flexibility, Creative BioMart also offers simultaneous DNA sequence modifications at multiple sites within a plasmid. ...
These new services can be applied to the detection of circulating autoantibodies/antigens in cells and cell membranes/ immune complexes in biopsy material/circulating immune cells. ...
For instance, the recent development of bispecific antibodies, where two antigen binding domains are incorporated into one antibody, requires careful design of the linker. ...
(Nasdaq: SGMO), a genomic medicine company, today announced dosing of the first patient in the Phase 1/2 STEADFAST clinical study evaluating TX200, a wholly-owned autologous Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation from a living donor. ...
VAXIMM’s plug and play DNA vaccination technology is based on a live attenuated, safe, orally available bacterial vaccine strain, which is modified to stimulate patients’ cytotoxic T-cells to target a wide range of cancer-related antigens. The platform allows for fast and scalable manufacturing of personalized T-cell cancer vaccines and may overcome key challenges ...
The study also showed increased antibody titers against 3 viral antigens (Spike – S1, Receptor Binding Domain - RBD and Nucleocapsid - NP) providing a broad immune response to COVID-19. ...
The main goal of the vaccine is to elicit a strong and long-lasting immune response against tumor antigens by targeting class I and class II epitopes. These two types of responses have been established as key factors in driving a sustained anti-tumor response. ...
"Ab Studio has unique capabilities in antibody development applying a computer-aided approach with conventional methods to design and optimize antibodies, and identify novel internalization antigen-binding sites," said Yue Liu, Founder and President of Ab Studio. ...
In the study, OMVs were decorated with the antigenic SARS-CoV-2 Spike receptor-binding domain and tested in a golden hamster infection model. ...